Yüklüyor......
Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
As the first oral multi-target anti-tumor drug proved for the treatment of patients with advanced liver cancer in 2007, sorafenib has changed the landscape of advanced hepatocellular carcinoma (HCC) treatment. However, drug resistance largely hinders its clinical application. Non-coding RNAs (ncRNAs...
Kaydedildi:
| Yayımlandı: | Front Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6848262/ https://ncbi.nlm.nih.gov/pubmed/31750247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01156 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|